148 related articles for article (PubMed ID: 36880753)
1. Empirical Treatment in Acute Bacterial Meningitis: a Plea for High Doses of Cefotaxime or Ceftriaxone.
Le Turnier P; Tattevin P; Varon E; Duval X
Antimicrob Agents Chemother; 2023 Apr; 67(4):e0001223. PubMed ID: 36880753
[No Abstract] [Full Text] [Related]
2. Vancomycin Should Be Part of Empiric Therapy for Suspected Bacterial Meningitis.
Olarte L
J Pediatric Infect Dis Soc; 2019 May; 8(2):187-188. PubMed ID: 30496558
[TBL] [Abstract][Full Text] [Related]
3. Bacteriologic outcome of children with cefotaxime- or ceftriaxone-susceptible and -nonsusceptible Streptococcus pneumoniae meningitis.
Olivier C; Cohen R; Begué P; Floret D
Pediatr Infect Dis J; 2000 Oct; 19(10):1015-7. PubMed ID: 11055609
[No Abstract] [Full Text] [Related]
4. Reply to Le Turnier et al., "Empirical Treatment in Acute Bacterial Meningitis: a Plea for High Doses of Cefotaxime or Ceftriaxone".
Cabellos C; Guillem L; Pelegrin I; Tubau F; Ardanuy C; Gudiol F; Ariza J; Viladrich PF
Antimicrob Agents Chemother; 2023 Apr; 67(4):e0005023. PubMed ID: 36880767
[No Abstract] [Full Text] [Related]
5. Bactericidal activity against intermediately cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with bacterial meningitis treated with high doses of cefotaxime and vancomycin.
Doit C; Barre J; Cohen R; Bonacorsi S; Bourrillon A; Bingen EH
Antimicrob Agents Chemother; 1997 Sep; 41(9):2050-2. PubMed ID: 9303415
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins.
Tan TQ; Schutze GE; Mason EO; Kaplan SL
Antimicrob Agents Chemother; 1994 May; 38(5):918-23. PubMed ID: 8067771
[TBL] [Abstract][Full Text] [Related]
7. Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children.
Goldwater PN
Int J Antimicrob Agents; 2005 Nov; 26(5):408-11. PubMed ID: 16216469
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic failure with high-dose cefotaxime in pneumococcal meningitis].
Michaus ML; Pérez-Díaz L; de Pablos M; Lezaun MJ; López-Bayón J
Enferm Infecc Microbiol Clin; 1997 May; 15(5):276-7. PubMed ID: 9376392
[No Abstract] [Full Text] [Related]
9. Penicillin- and Cephalosporin-Resistant Pneumococcal Meningitis: Treatment in the Real World and in Guidelines.
Cabellos C; Guillem L; Pelegrin I; Tubau F; Ardanuy C; Gudiol F; Ariza J; Viladrich PF
Antimicrob Agents Chemother; 2022 Dec; 66(12):e0082022. PubMed ID: 36326246
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of combined ceftriaxone and dexamethasone therapy in experimental cephalosporin-resistant pneumococcal meningitis.
Cabellos C; Martínez-Lacasa J; Tubau F; Fernández A; Viladrich PF; Liñares J; Gudiol F
J Antimicrob Chemother; 2000 Mar; 45(3):315-20. PubMed ID: 10702550
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of Streptococcus pneumoiae meningitis in infants].
Bingen E; Cohen R; Bourrillon A
Arch Pediatr; 1994 Aug; 1(8):756-8. PubMed ID: 7654271
[TBL] [Abstract][Full Text] [Related]
12. High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins.
Viladrich PF; Cabellos C; Pallares R; Tubau F; Martínez-Lacasa J; Liñares J; Gudiol F
Antimicrob Agents Chemother; 1996 Jan; 40(1):218-20. PubMed ID: 8787909
[TBL] [Abstract][Full Text] [Related]
13. Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in children.
Scholz H; Hofmann T; Noack R; Edwards DJ; Stoeckel K
Chemotherapy; 1998; 44(2):142-7. PubMed ID: 9551246
[TBL] [Abstract][Full Text] [Related]
14. A randomised comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults. Meropenem Meningitis Study Group.
Schmutzhard E; Williams KJ; Vukmirovits G; Chmelik V; Pfausler B; Featherstone A
J Antimicrob Chemother; 1995 Jul; 36 Suppl A():85-97. PubMed ID: 8543502
[TBL] [Abstract][Full Text] [Related]
15. Mortality indicators in pneumococcal meningitis: therapeutic implications.
Erdem H; Elaldi N; Öztoprak N; Sengoz G; Ak O; Kaya S; Inan A; Nayman-Alpat S; Ulu-Kilic A; Pekok AU; Gunduz A; Gozel MG; Pehlivanoglu F; Yasar K; Yılmaz H; Hatipoglu M; Cicek-Senturk G; Akcam FZ; Inkaya AC; Kazak E; Sagmak-Tartar A; Tekin R; Ozturk-Engin D; Ersoy Y; Sipahi OR; Guven T; Tuncer-Ertem G; Alabay S; Akbulut A; Balkan II; Oncul O; Cetin B; Dayan S; Ersoz G; Karakas A; Ozgunes N; Sener A; Yesilkaya A; Erturk A; Gundes S; Karabay O; Sirmatel F; Tosun S; Turhan V; Yalci A; Akkoyunlu Y; Aydın E; Diktas H; Kose S; Ulcay A; Seyman D; Savasci U; Leblebicioglu H; Vahaboglu H
Int J Infect Dis; 2014 Feb; 19():13-9. PubMed ID: 24211227
[TBL] [Abstract][Full Text] [Related]
16. Penicillin and ceftriaxone susceptibility of Streptococcus pneumoniae isolated from cerebrospinal fluid of children with meningitis hospitalized in a tertiary hospital in Israel.
Waisbourd-Zinman O; Bilavsky E; Tirosh N; Samra Z; Amir J
Isr Med Assoc J; 2010 Apr; 12(4):225-8. PubMed ID: 20803882
[TBL] [Abstract][Full Text] [Related]
17. Time-kill studies of antimicrobial combinations including cefotaxime, ceftriaxone, vancomycin and meropenem against cephalosporin-resistant Streptococcus pneumoniae.
Kim BN; Woo JH; Kim YS; Ryu J; Kim MN; Pai CH
Chemotherapy; 2000; 46(5):303-8. PubMed ID: 10965094
[TBL] [Abstract][Full Text] [Related]
18. Bacterial isolates from cerebrospinal fluid of children with suspected acute meningitis in a Nigerian tertiary hospital.
Nwadioha SI; Nwokedi EO; Onwuezube I; Egesie JO; Kashibu E
Niger Postgrad Med J; 2013 Mar; 20(1):9-13. PubMed ID: 23661203
[TBL] [Abstract][Full Text] [Related]
19. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis.
Fernández A; Cabellos C; Tubau F; Maiques JM; Doménech A; Ribes S; Liñares J; Viladrich PF; Gudiol F
J Antimicrob Chemother; 2005 Jan; 55(1):78-83. PubMed ID: 15546968
[TBL] [Abstract][Full Text] [Related]
20. [Antibiotherapy as first choice in infectious meningitis].
Cohen R; de La Rocque F; Varon E; Geslin P
Pediatrie; 1993; 48(1):37-49. PubMed ID: 8392691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
